A new treatment for this disease, as first reported by Kahook and colleagues, involves the use of a novel group of medications known as anti-VEGF agents.
Novi tretman za tu bolest, koju je prvi izvijestio Kahook i njegovi kolege, uključuje korištenje nove skupine lijekova poznatih kao Anti-VEGF agensi.